U.S. Capital Markets Stock News

NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

Did Record Q1 Results and New AI JV Just Shift RadNet's (RDNT) Investment Narrative?

In the first quarter ended March 31, 2026, RadNet, Inc. reported record revenue of US$575.63 million versus US$471.40 million a year earlier, while reducing its net loss to US$33.47 million from US$37.93 million and narrowing basic and diluted loss per share from US$0.51 to US$0.43. RadNet also formed a new joint venture with Saint Alphonsus Health System in Idaho, combining five outpatient imaging centers with its DeepHealth AI platform to enhance clinical reporting and operational...
NasdaqGS:AMAT
NasdaqGS:AMATSemiconductor

Applied Materials TSMC AI Chip Partnership Meets Stretched Valuation Concerns

Applied Materials (NasdaqGS:AMAT) and TSMC announced a new co-innovation partnership focused on advanced semiconductor technologies for AI. The collaboration targets faster development and commercialization of next generation AI hardware process technologies. This news adds a fresh chapter to the Applied Materials story beyond prior coverage of its NEXX acquisition and advanced packaging efforts. Applied Materials sits at the heart of chip manufacturing equipment, and this new partnership...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Assessing Intel (INTC) Valuation After Apple Foundry Deal And AI Earnings Momentum

Intel (INTC) is back in the spotlight after reports of a preliminary agreement to manufacture chips for future Apple devices, alongside strong Q1 results tied to AI CPU demand and industry partnerships. See our latest analysis for Intel. Those headlines have arrived alongside a sharp re-rating in the stock, with a 30 day share price return of 100.26% and a 1 year total shareholder return of 463.21% pointing to strong momentum after a long rebuilding period. If the recent Intel rally has you...
NYSE:VST
NYSE:VSTRenewable Energy

Why Vistra (VST) Is Down 8.2% After Record Q1 Results And Investment-Grade Upgrades – And What’s Next

Vistra Corp. recently reported first-quarter 2026 results showing sales of US$5.64 billion and net income of US$1.03 billion, alongside record adjusted EBITDA and continued progress on data center power agreements with major technology customers. Over the same period, the company completed a multiyear US$6.13 billion share repurchase program and secured an investment-grade credit rating upgrade from two major agencies, underscoring its balance sheet strength and capital returns focus. With...
NasdaqGS:CRDO
NasdaqGS:CRDOSemiconductor

Expanded AI Optical Portfolio Might Change The Case For Investing In Credo Technology Group Holding (CRDO)

In recent months, Credo Technology Group Holding expanded its high-speed connectivity and optical interconnect portfolio, including the acquisition of Hyperlume in 2025 and the launch of its Cardinal 1.6T optical DSP family for AI data centers. This combination of broader AI-focused offerings and enhanced Micro LED-based optical capabilities positions Credo more firmly within next-generation data infrastructure buildouts for major hyperscalers. Next, we'll examine how Credo's Hyperlume...
NYSE:DLR
NYSE:DLRSpecialized REITs

Does Digital Realty’s US$7.5 Billion ATM and Talent Push Reshape the Bull Case for DLR?

In early May 2026, Digital Realty Trust, Inc. filed for an at-the-market follow-on equity offering of up to US$7.50 billion in common stock, while also announcing a global partnership with DCD Academy to deliver a data center operations workforce development program through its New Hire Accelerate Pathways onboarding. This combination of large-scale equity issuance capacity and a global talent-building initiative highlights how Digital Realty is simultaneously strengthening its balance sheet...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Should FDA’s LEQEMBI IQLIK Review Delay Reshape How Biogen (BIIB) Investors View Alzheimer’s Strategy?

Eisai and Biogen recently announced that the FDA has extended by three months its review of the supplemental Biologics License Application for LEQEMBI IQLIK, a once-weekly subcutaneous starting dose for early Alzheimer’s disease, moving the PDUFA action date to August 24, 2026, after requesting additional information classified as a major amendment. While the FDA extension slows the U.S. timeline, the absence of raised approvability concerns and LEQEMBI’s broad global approvals keep...
NasdaqGS:UAL
NasdaqGS:UALAirlines

United Airlines (UAL) Deepens Peacock Tie-Up: What Does Its Transatlantic Bet Reveal About Premium Demand?

In early May 2026, United Airlines announced it had already launched a dedicated inflight entertainment channel featuring Peacock content across more than 160,000 seatback screens and personal devices, and just days earlier it began operating new nonstop routes from Newark/New York to destinations including Split, Bari, Glasgow and Santiago de Compostela. Together, these moves underline United’s push to differentiate its onboard experience while deepening its presence on higher-yielding...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

Walmart (WMT) Valuation Check After Steady One Year Shareholder Returns And Growth Expectations

With no fresh headline event driving Walmart (WMT) today, attention turns to how the stock’s recent performance and fundamentals line up, including its one-month and three-month returns, as well as revenue and net income trends. See our latest analysis for Walmart. Walmart’s recent 30-day share price return of 2.89% and year to date gain of 15.67%, alongside a 1-year total shareholder return of 35.94%, point to steady, positive momentum rather than a sharp re-rating. If that trend has you...
NYSE:PLNT
NYSE:PLNTHospitality

A Look At Planet Fitness (PLNT) Valuation After Guidance Cut And Paused Black Card Price Hike

Planet Fitness (PLNT) just reported Q1 2026 results that beat expectations on revenue and earnings. However, the stock dropped sharply after management cut full year growth guidance and paused a planned Black Card price increase. See our latest analysis for Planet Fitness. The sharp guidance cut and paused pricing move have reset expectations, with the 7 day share price return down 27.51% and the 1 year total shareholder return down 51.31%. This signals fading momentum despite the latest...
NasdaqGS:ASTE
NasdaqGS:ASTEMachinery

Astec Industries (ASTE) Valuation Check After Q1 Revenue Strength And Profit Margin Miss

Astec Industries (ASTE) just reported first quarter 2026 results that combined strong revenue and backlog with weaker profit margins, as cost inflation, product mix, and higher tariffs and trade show spending reduced earnings. See our latest analysis for Astec Industries. Astec Industries' 1 day share price return of 0.64% comes after the Q1 miss on profit. The 7 day and 30 day share price returns are down 13.34% and 12.87%. By contrast, the year to date share price return of 19.52% and 1...
NasdaqGS:NTRS
NasdaqGS:NTRSCapital Markets

Assessing Northern Trust (NTRS) Valuation After Its Role In Europe’s First Autocallable ETF Launch

ETF launch puts Northern Trust’s expertise in focus Northern Trust (NTRS) recently supported the launch of the first autocallable ETF in Europe on the Waystone ETF ICAV platform, an event that draws attention to its role in complex asset servicing. The new Calamos Autocallable Income UCITS fund uses a derivatives based, synthetic approach that aims to mirror a benchmark tracking a diversified basket of synthetic autocallable notes. For you as an investor, this highlights Northern Trust’s...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

Is It Too Late To Consider EyePoint (EYPT) After A 133% One-Year Surge?

Wondering whether EyePoint at US$13.66 still offers value after a big run, or whether most of the opportunity is already priced in. The stock is up 133.5% over the past year and 127.7% over three years, even though it has fallen 1.4% over the last week, 3.7% over the past month and 21.9% year to date. Recent market attention on EyePoint has focused on its position within the US pharmaceuticals and biotech space and how investors are reassessing risk across smaller healthcare stocks...
NYSEAM:UEC
NYSEAM:UECOil and Gas

New ISR Mine Launch Could Be A Game Changer For Uranium Energy (UEC)

Uranium Energy Corp. has recently received regulatory approval and begun production at its Burke Hollow in‑situ recovery uranium mine, while also commissioning additional header houses at its Christensen Ranch operation to expand wellfield capacity. This marks the first new U.S. in‑situ recovery uranium mine in more than a decade, underlining Uranium Energy’s push to scale domestic uranium supply and broaden its operational footprint across key producing hubs. We’ll now examine how the...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Is It Too Late To Consider Broadcom (AVGO) After A 96% One Year Share Price Surge?

If you are wondering whether Broadcom at around US$430 a share still offers value, the key question is how that price compares with what the business may be worth. The stock has posted returns of 3.2% over the last week, 15.7% over the last month, 23.7% year to date and 95.6% over the past year, which naturally raises questions about growth expectations and risk. Recent coverage has focused on Broadcom's role in semiconductors and related technology, with attention on how the company fits...
NYSE:CMRE
NYSE:CMREShipping

Costamare (CMRE) Is Up 9.2% After Dividend Hike Despite Lower Q1 Earnings Has The Bull Case Changed?

In late April 2026, Costamare Inc. reported first quarter 2026 results showing revenue of US$211.06 million and net income of US$80.4 million, while also indicating it would propose raising its quarterly dividend from US$0.115 to US$0.125 per common share beginning in the second quarter of 2026. This combination of lower year‑on‑year earnings and a planned dividend increase gives investors fresh insight into how management is balancing current profitability with cash returns to...
NYSE:GEV
NYSE:GEVElectrical

GE Vernova’s Dogger Bank Role Grows As Valuation Questions Persist

GE Vernova (NYSE:GEV) has selected Scotland’s Maraen Port of Nigg as the marshalling hub for turbine components for the Dogger Bank Wind Farm phases B and C. The port will handle logistics and staging activity for upcoming project phases, supporting one of the world's largest offshore wind developments. This appointment adds another large offshore wind project to GE Vernova’s execution pipeline in the European renewables supply chain. For investors following NYSE:GEV, this move underlines...
NasdaqGS:ECPG
NasdaqGS:ECPGConsumer Finance

Did Encore’s Refinancing And Upgraded 2026 Outlook Just Shift Encore Capital Group's (ECPG) Investment Narrative?

Encore Capital Group has recently announced a private offering of US$550 million senior secured notes due 2032 to institutional investors, with the proceeds earmarked to redeem existing US$500 million 9.250% senior secured notes due 2029 and EUR 200 million of its EUR 415 million floating rate notes due 2028, while covering related premiums, interest, and transaction costs. Alongside this refinancing move, Encore reported strong first quarter 2026 results with higher revenue, net income, and...
NasdaqGS:EWBC
NasdaqGS:EWBCBanks

The Bull Case For East West Bancorp (EWBC) Could Change Following Robust Q1 Earnings And Equity Pressure - Learn Why

In the past quarter, East West Bancorp reported a 23% rise in net income to US$358 million for Q1 2026, supported by higher net interest income, loan growth to US$58.10 billion, deposit growth to US$68.90 billion, and a lower provision for credit losses. An increase in unrealized losses on available-for-sale securities and cash flow hedges widened accumulated other comprehensive loss to US$388.20 million, slightly reducing total stockholders’ equity even as core operations strengthened. We...
NYSE:JOBY
NYSE:JOBYAirlines

ITC Probe Clouds Delta Joby Partnership And Raises NYSE JOBY Risk Profile

Delta Air Lines has warned that an ongoing US International Trade Commission probe could disrupt its partnership with Joby Aviation (NYSE:JOBY). The investigation is tied to patent infringement allegations brought by competitor Archer Aviation. Delta indicated that an adverse outcome could potentially restrict or remove Joby eVTOL aircraft from the US market. Joby Aviation, which is developing electric vertical take off and landing aircraft for short distance passenger flights, has been a...
NYSE:HE
NYSE:HEElectric Utilities

A Look At Hawaiian Electric (HE) Valuation After Maui Settlement Credit Upgrade And Q1 Earnings

Hawaiian Electric Industries (HE) is back in focus after finalizing the global Maui wildfire settlement and making the first of four annual payments, alongside first quarter earnings and a credit rating upgrade from Moody's. See our latest analysis for Hawaiian Electric Industries. There has been a sharp reset in sentiment, with the share price down 11.2% over the past 90 days but still up 17.4% year to date. The 1 year total shareholder return of 38.7% contrasts with a much weaker 3 and 5...
NasdaqGS:SNDX
NasdaqGS:SNDXBiotechs

Assessing Syndax Pharmaceuticals (SNDX) Valuation After Stronger Revenue And Narrower Losses

Why the latest earnings matter for Syndax Pharmaceuticals (SNDX) Syndax Pharmaceuticals (SNDX) reported first quarter 2026 revenue of US$64.86 million compared with US$20.04 million a year earlier, with net loss narrowing to US$42.67 million and loss per share at US$0.48, down from US$0.98. See our latest analysis for Syndax Pharmaceuticals. Alongside the stronger quarterly figures, Syndax Pharmaceuticals’ recent price action has been mixed, with a 7 day share price return of 7.67% and a 30...
NasdaqCM:ASTH
NasdaqCM:ASTHHealthcare

A Look At Astrana Health (ASTH) Valuation After A Sharp Multi‑Period Share Price Rally

Astrana Health stock performance snapshot Astrana Health (ASTH) has drawn investor attention after a strong recent run, with the stock up 8.9% in the past day, 12.3% over the week, and 42.2% over the past month. See our latest analysis for Astrana Health. Those short term share price moves sit on top of a much stronger run, with a 90 day share price return of 103.9% and a 1 year total shareholder return of 37.7%. This points to building momentum as investors reassess Astrana Health's growth...
NasdaqCM:QUBT
NasdaqCM:QUBTTech

Assessing Quantum Computing’s Valuation After A 36% Monthly Rebound And Very Large Three Year Return

Why Quantum Computing stock is back on investors’ radar Quantum Computing (QUBT) has moved back into focus after a sharp month move of 36%, prompting investors to reassess how its photonics based quantum and AI hardware story fits into their portfolios. See our latest analysis for Quantum Computing. At a share price of $9.60, Quantum Computing’s recent 36% 30 day share price return stands in contrast to its year to date share price decline of 12.8%, while the 3 year total shareholder return...